RFC
NVNO

Regions Financial Corp’s enVVeno Medical NVNO Stock Holding History

Regions Financial Corp’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,957
Closed -$273K – 881
2025
Q2 		$273K Buy
+1,957
New +$231K ﹤0.01% 739

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Regions Financial Corp's NVNO Position: Q3 2025 in Review

Regions Financial Corp sold out of enVVeno Medical (NVNO) in Q3 2025, closing a stake of 1,957 shares — an estimated $273K sold.

Regions Financial Corp first reported a position in NVNO in Q2 2025 and held it in 1 quarter. The position peaked at $273K in Q2 2025. 36 funds tracked by Wall St. Rank hold NVNO as of Q3 2025.

  • Regions Financial Corp reported no remaining enVVeno Medical position as of Q3 2025 after selling out during the quarter.
  • Regions Financial Corp sold 1,957 enVVeno Medical shares in Q3 2025, an estimated $273K.
  • Regions Financial Corp first reported a position in enVVeno Medical in Q2 2025 and held it in 1 quarter.
  • Regions Financial Corp's enVVeno Medical position peaked at $273K in Q2 2025.
  • 36 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2025.

Based on Regions Financial Corp's 13F filing for Q3 2025, filed 19 Nov 2025.